Hypersomnia in Guillain-Barré Syndrome: A Co-incidental or an Aetiological Association?
PDF
Cite
Share
Request
Case Report
P: 166-169
June 2021

Hypersomnia in Guillain-Barré Syndrome: A Co-incidental or an Aetiological Association?

J Turk Sleep Med 2021;8(2):166-169
1. Bursa Uludağ Üniversitesi Tıp Fakültesi, Nöroloji Anabilim Dalı, Bursa, Türkiye
No information available.
No information available
Received Date: 28.01.2021
Accepted Date: 09.03.2021
Publish Date: 26.05.2021
PDF
Cite
Share
Request

ABSTRACT

Increased daytime sleepiness, hypersomnia, is a very common symptom in the general population and may cause serious problems in their lives. Hypersomnia may be idiopathic or may occur secondary to other aetiologies. Infections and vaccinations may also be related to hypersomnias. A 74-year-old man complaining of muscle weakness after severe diarrhoea was admitted and diagnosed with Guillain-Barré syndrome (GBS). He also complained of increased daytime sleepiness since the emergence of his weakness, for which all metabolic and endocrine aetiologies were excluded. A full night polysomnography and multiple sleep latency test revealed objective daytime sleepiness and tree episodes of rapid eye movements during sleep periods. Because of the temporal association, the patient was diagnosed with secondary narcolepsy secondary to post-infectious GBS.

Keywords: Hypersomnia, Guillain-Barré syndrome, polysomnography, multiple sleep latency test

References

1
American Academy of Sleep Medicine. International classification of sleep disorders. Diagnostic and coding manual. 3rd ed. American Academy of Sleep Medicine, Westchester, IL, 2014.
2
Bollu PC, Manjamalai S, Thakkar M, Sahota P. Hypersomnia. Mo Med 2018;115:85-91.
3
Dauvilliers Y, Buguet A. Hypersomnia. Dialogues Clin Neurosci 2005;7:347-56.
4
Clark IA, Vissel B. Inflammation-sleep interface in brain disease: TNF, insulin, orexin. J Neuroinflammation 2014;11:51.
5
Krueger JM, Majde JA, M.Rector. Cytokines in immune function and sleep regulation. Handb Clin Neurol 2011;98:229-40.
6
Han F, Lin L, Warby SC, Faraco J, Li J, Dong SX, An P, Zhao L, Wang LH, Li QY, Yan H, Gao ZC, Yuan Y, Strohl KP, Mignot E. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 2011;70:410-7.
7
Nohynek H, Jokinen J, Partinen M, Vaarala O, Kirjavainen T, Sundman J, Himanen SL, Hublin C, Julkunen I, Olsen P, Heikkila SO, Kilpi T. AS03 adjuvanted AH1N1vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 2012;7:1-9
8
Savrun Y, Demir AB, Sıvacı AÖ, Bora İ, Zarifoğlu M. Our cases of secondary narcolepsy with three different etiology: review of the literature. J Turk Sleep Med 2015;2:72-6.
9
Peralta A, Bentes C, Santos R. Clinical and polysomnographic status dissociatus in Guillain Barre syndrome. Clin Neurophysiol 2006;117:106-7
10
Kanbayashi T, Ishiguro H, Aizawa R, Saito Y, Ogawa Y, Abe M, Hirota K, Nishino S, Shimizu T. Hypocretin-1 (orexin-A) concentrations in cerebrospinal fluid are low in patients with Guillain-Barré syndrome. Psychiatry Clin Neurosci 2002;56:273-4.
11
Maier H, Schmidbauer M, Pfausler B, Schmutzhard E, Budka H. Central nervous system pathology in patients with the Guillain-Barré syndrome. Brain 1997;120:451-64.
2024 ©️ Galenos Publishing House